.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204242

« Back to Dashboard
NDA 204242 describes ZUBSOLV, which is a drug marketed by Orexo Us Inc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and three Paragraph IV challenges. Additional details are available on the ZUBSOLV profile page.

The generic ingredient in ZUBSOLV is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

Summary for NDA: 204242

Tradename:
ZUBSOLV
Applicant:
Orexo Us Inc
Ingredient:
buprenorphine hydrochloride; naloxone hydrochloride
Patents:6
Formulation / Manufacturing:see details

Pharmacology for NDA: 204242

Suppliers and Packaging for NDA: 204242

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZUBSOLV
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL 204242 NDA Orexo US, Inc. 54123-114 54123-114-30 3 BLISTER PACK in 1 CARTON (54123-114-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
ZUBSOLV
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL 204242 NDA Orexo US, Inc. 54123-914 54123-914-30 3 BLISTER PACK in 1 CARTON (54123-914-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;SUBLINGUALStrengthEQ 1.4MG BASE;EQ 0.36MG BASE
Approval Date:Jul 3, 2013TE:RLD:No
Patent:8,940,330Patent Expiration:Sep 18, 2032Product Flag?YSubstance Flag?Delist Request?
Patent:9,259,421Patent Expiration:Sep 18, 2032Product Flag?YSubstance Flag?Delist Request?
Patent:9,439,900Patent Expiration:Sep 18, 2032Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc